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Abstract 
Introduction. Rating the quality of a body of evidence is an increasingly common 
component of research syntheses on intervention effectiveness. This study sought to identify 
and examine existing systems for rating the quality of a body of evidence on the effectiveness 
of health and social interventions. 
 
Methods.  We used a multi-component search strategy to search for full-length reports of 
systems for rating the quality of a body of evidence on the effectiveness of health and social 
interventions published in English from 1995 onward. Two independent reviewers extracted 
data from each eligible system on the evidence domains included, as well as the development 
and dissemination processes for each system. 
 
Results.  Seventeen systems met our eligibility criteria. Across systems, we identified 
thirteen discrete evidence domains: study design, study execution, consistency, measures of 
precision, directness, publication bias, magnitude of effect, dose-response, plausible 
confounding, analogy, robustness, applicability and coherence. We found little reporting of 
rigorous procedures in the development and dissemination of evidence rating systems. 
 
Conclusion.  We identified 17 systems for rating the quality of a body of evidence on 
intervention effectiveness across health and social policy. Existing systems vary greatly in the 
domains they include and how they operationalise domains, and most have important 
limitations in their development and dissemination. The construct of the quality of the body 
of evidence was defined in a few systems largely extending the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) approach. GRADE was found to be 
unique in its comprehensive guidance, rigorous development and dissemination strategy. 
 
 
Keywords: intervention effectiveness, systematic review, guideline, evidence rating, 
GRADE, public health 
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1. Introduction 
Rating the quality of a body of evidence is an increasingly common component of 
systematic reviews and practice guidelines on intervention effectiveness. While assessing 
risks of bias in each individual study included in a research synthesis is an important and 
well-established practice,
1,2
 rating the quality of a body of evidence is a comparatively new 
practice that indicates the credibility and trustworthiness of the totality of evidence across 
studies in relation to a specific research question.
3,4
 Systems for rating the quality of a body 
of evidence have been predominantly discussed and applied in health-related systematic 
reviews and clinical guideline development.
5,6
 The Cochrane Collaboration was the first 
organisation to attempt to integrate the rating of a body of evidence as a mandatory procedure 
in research syntheses on intervention effectiveness. Specifically, Cochrane mandated use of 
the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
approach in the conduct of Cochrane intervention reviews.
4
 Over the last decade, GRADE 
and other approaches for rating the quality of a body of evidence have proliferated. The 
GRADE approach, specifically, is currently used by over 80 organisations worldwide.
7
  
Systems for rating the quality of a body of evidence typically involve an examination 
of various characteristics of evidence that ultimately results in a rating of that body of 
evidence. For example, in the GRADE approach, the process of rating starts with a 
consideration of the designs of included studies: if the body of evidence contributing to an 
outcome consists of randomised controlled trials (RCTs), the quality of a body of evidence is 
initially given a rating of ―high‖, while a body of evidence consisting of non-randomised 
studies (NRS) is initially given a rating of ―low‖.8 The body of evidence is then assessed by 
considering eight further domains. Assessments within five domains—risk of bias, 
indirectness, inconsistency, imprecision and publication bias—are used to downgrade the 
initial rating. For a body of evidence consisting of NRS, assessments within the three 
remaining domains—magnitude of the effect, dose-response relationship in the effect, and 
counteracting plausible residual bias or confounding—may be used to upgrade the initial 
―low‖ rating. Quality (―certainty‖ is also another frequently used term) of evidence is 
ultimately categorised into one of four ratings—high, moderate, low and very low—that 
reflect the extent to which the review authors are confident or certain that an estimate of the 
effect for a specific outcome is correct.
8
   
 As use of evidence rating systems has increased, so have reports of challenges faced 
by those attempting to use these systems—particularly for research syntheses on social and 
public health interventions, which are often described as ―complex‖.9-12 Interventions are 
viewed as complex for a variety of reasons. Some dimensions of complexity are ascribed to 
aspects of the interventions themselves,
13,14
 such as interventions with multiple components 
that aim to address different and multiple causes of the problems (e.g., both biological and 
social). Other dimensions of complexity are seen as emanating from system properties;
15
 that 
is to say, long, non-linear, and dynamic relationships between interventions and outcomes, 
interactions and interdependencies between different components of interventions, and levels 
of target.
16
 Consideration of complexity may require additional guidance when rating the 
quality of a body of evidence.
11,12,17
 Study design is often a key issue, given that RCTs are 
not feasible or appropriate for many population-level interventions. In addition, many 
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researchers acknowledge that multifaceted heterogeneity between studies in systematic 
reviews of complex interventions is a more difficult type of problem, and requires specific 
procedures of planning and analysis.
18
 There are also concerns that narrow perspectives on 
evidence synthesis and the process of rating the quality of a body of evidence with simple 
hypotheses about the causal relationships may result in naïve and misleading synthesis 
results.
19,20
 Furthermore, there are ambiguities around how best to conceptualise and interpret 
the construct of the quality of the body of evidence on the effectiveness of an intervention, 
when effects are contingent upon intervention programming, implementation and contextual 
factors.
12
  
 
1.1. Objectives 
In view of the challenges reported in applying quality of a body of evidence rating 
outside of biomedical settings and interventions,
11,12
  this paper sets out to systematically 
review systems for rating the quality of a body of evidence on intervention effectiveness, 
including systems from health and social policy. Previous systematic reviews investigating 
evidence rating systems have mainly focused on scientific evidence in biomedical contexts 
and have not included systems from social policy domains such as public health, education, 
and crime and justice.
21,22
  
The key objectives of this systematic review therefore are to: 
 1) Identify existing systems for rating the quality of a body of evidence on 
intervention effectiveness across health and social policy; 
 2) Examine how these systems describe the construct of the quality of a body of 
evidence and map out discrete domains they use to rate that quality; 
3) Describe the reported procedures used to develop and disseminate the systems.  
The resultant ―state of the field‖ map of the systems can be used by any reviewer to 
identify and adopt systems and domains for rating the quality of a body of evidence that are 
relevant for their specific needs. 
  
2. Methods 
2.1. Eligibility criteria 
Methods of this systematic review are described in detail in an a priori developed 
protocol (see Supplementary File 1). To be included in this review, a system had to (1) 
comprise a full-length document reporting a procedure for rating the quality of a body of 
evidence, derived from evidence synthesis that integrates results across individual studies on 
the effectiveness of health or social interventions; (2) be published in English from 1995 
onward, when evidence rating was first proposed as a stage of research synthesis.
23
 Where a 
document discussed a system developed by others (e.g., a literature review), we retrieved the 
original documents reporting those systems and examined them for eligibility.  We excluded 
documents if they described a procedure for rating the quality of a body of evidence on 
intervention effectiveness for a specific clinical topic (e.g., systems used in specific 
guidelines on osteoarthritis, brain injury), as these are largely covered by the two previous 
systematic reviews.
21,22
 We also excluded systems that were no longer used by an 
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organisation (e.g., the systems previously used by the Scottish Intercollegiate Guidelines 
Network and the Institute for Clinical Systems Improvement, before these organisations 
adopted the GRADE approach). Information on suspended use of these systems was either 
directly available on the organisation’s website, or was obtained through email 
communication with representatives of the organisation.  
2.2. Systematic search strategy  
We used a multi-component search strategy with multiple sources in an attempt to 
maximise the sensitivity of the search. First, we updated search strategies used in previous 
systematic reviews
21,22
 and expanded them to include social science databases. We ran these 
searches on 2 June 2016 in the following databases: Applied Social Sciences Index (ASSIA), 
Cochrane Methodology Register (Cochrane Library), EMBASE, MEDLINE, PsycINFO, 
SCIE Social Care Online, Scopus Social Sciences, and Social Sciences Citation Index (Web 
of Knowledge). Next, using the expertise of the authors and through bibliography searches of 
the related literature we located and searched the websites of 83 key stakeholder 
organisations that specifically aim to aggregate, review, and assess evidence across social 
policy domains, such as child and family welfare, international development, crime and 
justice, public health, and education (see Supplementary File 1 for the search strategy). 
Thirdly, we searched bibliographies of all the included documents and literature reviews 
containing secondary reporting of eligible systems. Finally, we consulted experts identified 
from the website searches to check whether we missed any systems.  
Screening of all titles, abstracts and full-text documents was conducted by the first 
author (AM) using the Rayyan web application for systematic reviews.
24
 A subset of 
randomly chosen titles (10%) was independently screened by a second author (JD). All 
discrepancies were discussed until agreement was reached.  
 
2.3. Data extraction 
We extracted data on four types of information. First, we extracted descriptive 
information about included systems, namely the author, year, title, publication source, and 
eligibility criteria. We then extracted information from each system on how its authors 
defined the construct of the quality of a body of evidence. We further extracted details of 
specific domains within the system used to rate the quality of a body of evidence, how these 
domains were defined, and how ratings of the quality of a body of evidence were categorised 
(e.g., ―high‖, ―moderate‖, or ―low‖). Extending the pre-specified domains for development 
and dissemination of research reporting guidelines,
25,26
 we looked at whether systems 
reported any preparatory activities, such as a review of literature on existing domains for 
rating a body of evidence and consensus based activities, such as a Delphi exercise and expert 
meetings. Finally, we looked for information on how the documents describing the systems 
were written up and disseminated, such as whether the authors of the systems described how 
they planned to address criticism and feedback for the system or whether the system was 
available on an open-access website.  
The first author (AM) and a second independent reviewer (either JD or a research 
assistant) extracted information about the content, development and dissemination of the 
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included systems into a Microsoft Excel spreadsheet. Three independent reviewers (AM, JD, 
ER) piloted the data extraction form on the same evidence rating system before continuing 
with the remaining systems. 
 
2.4. Data synthesis 
 We employed a three-step procedure to describe the domains of evidence for rating 
the quality of a body of evidence in the included systems. First, we created an inventory of all 
identified domains by using cross-case tables.
27
 We examined these tables to compare how 
the domains for rating the quality of a body of evidence were labeled, defined, and 
operationalised across included systems. We then compiled a discrete (i.e., non-redundant) 
list of domains of evidence considered in the included systems. Systems used different 
terminology to denote similar constructs and domains of evidence (for example, aspects of 
the domain that is termed as ―imprecision‖ in the GRADE approach were covered by 
―precision‖ in the system used by the Agency for Healthcare Research and Quality (AHRQ) 
and fell under the domain termed ―clinical impact‖ in the system adopted by the National 
Health and Medical Research Council (NHMRC) of Australia).  Where such overlap existed, 
we mainly followed the terminology of the GRADE approach to describe the discrete set of 
domains. We supplemented this with a list of additional domains that are not currently 
considered in the GRADE approach, but were found in other systems, and followed the 
terminology used in the systems to describe these domains. Finally, to help readers to 
visualise findings, we created a heat map summarising how the systems reported the 
identified discrete domains of evidence (see Figure 1). By using different colour shades, the 
heat map describes whether these domains of evidence are reported in each included system 
or not. Where a system reported the domain and yet did not provide specific criteria and 
guidance for rating it, the map denotes those as a different category of reporting (i.e., with a 
brighter shade). Similar to this, we developed a second heat map describing how authors 
reported activities underpinning the development and dissemination of the included systems 
(see Figure 2). Both of these heat maps were developed by one author (AM) and further 
verified by the second author (JD).  
3. Results 
We identified 11,758 records after duplicates were removed. After title and abstract 
screening, we assessed the full-texts of 141 records, from which 28 records were found to be 
eligible for inclusion in this review. Overall, these 28 records describe 17 evidence rating 
systems (see Figure 3 for the PRISMA flow diagram).  
3.1. Excluded studies 
Of the 113 records excluded at full text, 45 involved literature reviews of evidence 
rating systems, 28 were editorials or conference abstracts, and four records were not 
published in English (Chinese, French, Portuguese and Spanish). Twenty-nine records 
described procedures and domains for categorising interventions on websites of different 
―what works‖ organisations, also known as evidence clearinghouses or evidence-based 
programme registers.
28
 Because these procedures and corresponding domains of evidence did 
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not consider a ―body of evidence‖, we excluded them from this review (a full list of these 
systems and their specific domains is available from the first author upon request). Through 
website searches and contacts with experts we established that six systems were no longer 
used.
23,29-33
 A further system, the Confidence in the Evidence from Reviews of Qualitative 
Research (CERQual), which is designed for sole application to a body of qualitative 
evidence, was not eligible for use in assessment of effectiveness evidence.
34
 
3.2. Characteristics of the sample 
Fourteen of the included systems were developed for healthcare, including general 
clinical and public health interventions (see Table 1). Only three systems were developed for 
other policy domains—specifically education, criminology, and international development.35-
37
 Three of the included systems were largely based on the GRADE approach,
38
 but 
introduced modifications that warrant their classification as separate systems.
39-41
 Ten 
systems mentioned specific research synthesis methods for which the system was developed; 
most referred to a meta-analysis or a ―narrative synthesis‖ without a single pooled effect 
estimate
42
 to synthesise data on the effects of an intervention. Only one system was explicitly 
described for use with a mixed-method approach to research synthesis.
36
 Eight of the systems 
described rating the quality of a body of evidence primarily within the context of research 
syntheses only, while eight others described rating the quality of a body of evidence for a 
guideline development context. Only the GRADE approach addressed the conceptual and 
procedural differences when using the domains of evidence for assessing a body of evidence 
for research synthesis versus guideline development contexts.
38
 
We identified inconsistencies in how included systems labelled and defined rating of 
the quality of a body of evidence overall and the components of that rating. The most 
frequently used terms to describe the overall rating of the quality of a body of evidence were 
strength of evidence, grades of evidence, quality, confidence, or certainty in 
evidence.
37,38,40,43-47
 In contrast, the most commonly used terms for assessing the conduct of 
individual included studies were levels of evidence, critical appraisal, quality appraisal, 
study limitations, risk of bias, and study quality.
37,43,44,48
 From these, terms such as levels of 
evidence, risk of bias and study limitations were mainly discussed with regard to assessing 
studies for bias and internal validity, while study quality, quality appraisal and critical 
appraisal were used to denote study execution more broadly with regard to eliminating 
threats to both internal and external validities. 
3.3. Defining quality of a body of evidence 
Only six systems—three of which are largely based on the GRADE approach—
provided a definition for the construct of the quality of a body of evidence on intervention 
effectiveness.
38-41,46,47
 In a systematic review context, the GRADE approach and three 
derivative systems defined quality of a body of evidence as “the extent of confidence that an 
estimate of the effect is correct”.38-40 The Guide to Community Preventive Services defined 
quality of a body of evidence as “confidence that changes in outcomes are attributable to the 
interventions”,46 and the U.S. Preventive Services Task Force (USPSTF) as the “likelihood 
that the assessment of the net benefit (i.e., benefits minus harms) of a preventive service is 
correct”.47 The USPSTF definition is similar to how the GRADE approach defines the 
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overall quality of a body of evidence in the context of guideline development, when 
considering all important outcomes associated with the intervention, including harms. In this 
context GRADE defines the overall quality of a body of evidence as “the extent of confidence 
that an estimate of the effect is adequate to support a particular decision or 
recommendation”.49 
 In order to assess the net benefit of a preventive service, the USPSTF system uses 
analytic frameworks, also called ―chain of evidence‖ diagrams to map out the specific 
linkages in the overall chain of evidence that must be present for a preventive service to be 
considered effective.
47
 The system assesses the quality of a body of evidence for each 
separate linkage in the chain of evidence to draw conclusions about the overall effectiveness 
of a preventive service. This approach is very similar to that adopted by the GRADE-
modified Grading of Evidence for Public Health Interventions (GEPHI) system.
41
 In addition 
to rating the quality of a body of evidence for the estimates of the effect of an intervention 
(which corresponds to the approach described in GRADE), the GEPHI system suggests to 
also rate the quality for the overall causal chain of an intervention. This rating of the 
confidence in the overall causal chain of an intervention is referred to as coherence of 
evidence assessment in the GEPHI system.
41
  
 
3.4. Mapping of evidence domains 
The evidence domains used to rate the quality of a body of evidence were often 
similar in concept across systems yet different in how they were described and 
operationalised. We encourage readers to use Table 1 and Figure 1 as two complementary 
sources of information on the identified evidence grading systems to examine the 
discrepancies in labelling and describing evidence domains. Table 1 provides an overview of 
the domains of evidence as they are reported in the original studies, while Figure 1 maps the 
thirteen discrete domains we identified in included systems and presents how they are 
reported in each of the included systems. More information on how the specific evidence 
domains were defined and operationalised in each system is presented in Supplementary File 
2. In the sections below, we briefly summarise the identified discrete set of domains of 
evidence (see Figure 1), as well as the reported activities underpinning the development and 
dissemination of these systems (see Figure 2). 
3.4.1. Study design  
Twelve systems included an evidence domain related to the design of the individual 
studies constituting the body of evidence. All but four of these systems
35,36,45,50
 described an 
―evidence hierarchy‖ approach that influenced how overall quality of a body of evidence was 
assessed. Procedurally, this entailed initially privileging a body of evidence from certain 
study designs (namely RCTs) as providing a higher quality (compared to other study designs) 
before assessing other evidence domains. While all systems with an evidence hierarchy 
approach placed evidence from RCTs at the top of this hierarchy, many further privileged 
specific non-randomised study designs over others. For example, the system used by the 
Joanna Briggs Institute
39
 suggested initial ratings of quality depending on whether a body of 
evidence consists of experimental (Level 1), quasi-experimental (Level 2), or observational 
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studies (Level 3). Similarly, the GRADE-modified GEPHI system for public health 
interventions recommends that a body of evidence consisting of non-randomised studies with 
controls or before and after [uncontrolled] studies have an initial rating of ―moderate‖ quality 
if these studies used methods to minimise selection bias and confounding.
41
 
 
3.4.2. Study execution  
Fifteen systems included an evidence domain related to assessing how well studies 
constituting the body of evidence were executed to minimise threats to internal and external 
validities (also labelled as quality of study execution, risk of bias, study limitations, study 
quality). In the majority of instances, however systems mainly included criteria to assess risks 
of bias or threats to the internal validity for assessing study execution. A few systems, 
however also included specific criteria for assessing the generalisability of the study results, 
that is, criteria related to the external validity of the individual studies in the body of 
evidence.  
Systems varied in how they operationalised assessment of study execution. Some 
systems used design-specific criteria, such as checklists or signaling questions for appraising 
RCTs
36,38,40,43
 or longitudinal studies.
43
 Most systems, however, described more generic 
criteria to assess study execution across various study designs included in the body of 
evidence.
37,45,46,48,50
  
3.4.3. Consistency 
Fourteen systems included an evidence domain related to the consistency of evidence. 
Generally, systems defined consistency as ―the extent to which findings are similar across 
included studies” in a body of evidence,48 usually in reference to the degree of similarity in 
the magnitude and/or direction of effect estimates. The majority of the systems, however did 
not report any specific criteria on how to rate consistency in the body of evidence. Only a few 
systems discussed specific procedures, such as statistical testing for heterogeneity to rate 
consistency in the body of evidence. The GRADE-modified GEPHI approach distinguished 
between two types of consistency ratings:
41
 the first type was identical to the domain of the 
GRADE approach termed as inconsistency and defined as “assessment of statistical 
heterogeneity in the estimates of the effect”.51 The second type of consistency rating was 
specified in the system as ―consistency‖ assessment and was defined as presence of 
“consistent evidence across a large number of settings, geographical locations and diverse 
epidemiological study designs”. The system argued that the fact that an intervention effect is 
reproducible under highly variable conditions suggests reduced likelihood that the observed 
effect is attributable to confounding or bias.
41
 This can increase a reviewer’s confidence in 
the body of evidence regarding the overall effectiveness of an intervention. 
 
3.4.4. Measures of precision 
Eleven systems included an evidence domain that we have classified as relating to 
measures of precision of the body of evidence: i.e., considerations of the impact that random 
error may have on effect estimates. Systems differed widely in the level of specification and 
sophistication they required for assessing precision of the body of evidence. For instance, 
many systems recommend only considering the number of studies in the body of evidence as 
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a measure of precision,
37,43,45,46,52
 however only one of these systems specifies a threshold for 
the minimum number of studies to be included in the body of evidence.
52
 Furthermore, only 
the GRADE approach and its variants described specific criteria for assessing precision with 
regard to the sufficiency of the sample size of the body of evidence.
38-41
 These systems 
assessed sufficiency of the sample size relative to an ―optimal information size‖: i.e., 
“number of patients (for continuous outcomes) and events (for dichotomous outcomes) that 
would be needed to regard a body of evidence as having adequate power”.53 In addition, 
these systems also considered the boundaries of confidence intervals for an effect estimate in 
relation to a null effect and a clinically important effect threshold to make an overall 
judgement about the precision of a body of evidence. The estimate of the effect of an 
intervention is judged to be less precise if the confidence interval is wide to include a null 
effect or a threshold, which is considered as clinically unimportant.
53
  
3.4.5. Directness 
 In general, systems used concepts of directness, applicability and generalisability of 
evidence interchangeably and inconsistently—often without providing clear definitions or 
specific criteria to guide the assessment.
35,37,47,48,50
 In addition, these terms were not 
necessarily used as synonyms across systems. For example, the system endorsed by the 
National Health and Medical Research Council (NHMRC) of Australia used the term 
―applicability‖ to address whether the body of evidence was relevant to the local context 
(including the organisational and cultural context), while the term generalisability was used 
to refer to how precisely a body of evidence answered a review or a guideline question in 
terms of populations and settings of interest.
48
 In order to disentangle the discrepancies in the 
terminology, we have used the terminology of the GRADE approach, namely ―directness‖ of 
evidence to describe the domains of evidence from the included systems related to the notion 
of comparability of the evidence to the original research question. We have identified six 
systems that used this domain of evidence to assess how directly the available evidence 
answers a review or a guideline question with regard to the Population, Intervention, 
Comparison and Outcomes (PICO) elements of the question.
35,39-41,48,54
  
3.4.6. Publication bias 
Five systems included publication bias as a domain for rating the quality of a body of 
evidence.
36,39-41,55
 All but one of these systems followed a definition of publication bias as 
used within the GRADE approach, that is “a failure to identify studies as a result of studies 
remaining unpublished or obscurely published”.55 The system used by AHRQ on the other 
hand, considered publication bias as only one type of potential bias within a broader domain 
of reporting biases, which was itself defined as a decision by authors or journals to report 
research findings based on their direction and magnitude of effect.
40
 Selective outcome 
reporting and selective analysis reporting were the other types of reporting biases described 
in this system.  
3.4.7. Magnitude of effect 
We identified seven systems, which included magnitude of effect as a distinct domain 
to rate the quality of a body of evidence on the effectiveness of health or social 
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interventions.
36,39-41,43,46,56,57
 However, only four of these systems specified the thresholds for 
what they considered to be a ―large‖ magnitude of effect.39,41,56,57 This predominantly 
included a relative risk (RR) greaten than 2, or less than 0.2, as suggested in the GRADE 
approach.
56 
3.4.8. Dose-response 
Overall, five systems considered dose-response as a distinct domain of evidence when 
rating the quality of a body of evidence on the effectiveness of health or social 
interventions.
39-41,47,56,57
 Systems commonly defined dose-response as a “pattern of a larger 
effect with greater exposure to an intervention”.40  
3.4.9. Plausible residuals 
All systems that followed the structure of the GRADE approach (overall four systems, 
including GRADE itself) considered counteracting confounding, as a domain to upgrade the 
quality of a body of evidence, when a body of evidence is mainly comprised of observational 
studies.
39-41,56
 Two possibilities were commonly applied: “if all plausible residual biases 
would diminish the observed effect, or if all plausible residual biases would suggest a 
spurious effect when no effect is observed”.56  
3.4.10. Analogy 
Only one system—the GEPHI system—included an evidence domain related to 
analogous evidence. The GEPHI system operationalised analogous evidence as supporting 
evidence from similar or ―analogous‖ interventions that are known to operate through the 
same or similar mechanisms, which if present could lead to a higher quality of a body of 
evidence rating.
41
 In the context of WHO guidelines on indoor air quality, the system 
discusses the example of how certainty in the effects of household air pollution from solid 
fuel can be enhanced by strong empirical evidence about the effects of second-hand or active 
smoking. In this example, both household air pollution and second-hand or active smoking 
expose individuals to similar combustion mixtures, and therefore are viewed as analogous 
pieces of evidence.
41
  
3.4.11. Robustness  
Robustness of evidence was described as a domain to rate the quality of a body of 
evidence by one system.
52
 The system suggests that reviewers measure robustness of 
evidence through sensitivity analysis with a priori defined thresholds. For example, a 
reviewer may decide a priori that a threshold for robustness assessment is one in which 
“confidence intervals of the last three cumulative, random-effects meta-analyses remain fully 
on the same side of zero after removing of the study with the smallest weight”.52  
3.4.12. Applicability 
 Four systems described applicability as a domain of evidence measuring the extent to 
which evidence may be applicable in a specific context.
37,47,48,50
 It is worth highlighting that 
we identified three additional systems,
40,45,46
 which considered applicability of evidence as a 
separate judgement when making recommendations for practice.  In these systems, discussion 
of applicability was held separately from other domains of evidence, and largely within a 
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context of guideline development. For example, the GRADE-based system endorsed by 
AHRQ clearly separates judgments of directness of evidence from that of applicability 
assessment. In this system, directness of evidence is defined to express “how closely the 
available measures an outcome of interest”, and relies on two judgments:40 the directness of 
the employed outcomes (i.e., whether the available evidence is in fact only a proxy for an 
ultimate outcomes of interest) and directness of comparisons (i.e., whether evidence derives 
from head-to-head comparisons). Meanwhile, the system defines applicability as the external 
validity of the evidence base with regard to different populations, and is considered 
explicitly, but separately from the overall rating of the quality of a body of evidence.
40
 
3.4.13. Coherence   
Only three systems included an evidence domain related to assessing the coherence of 
the causal pathway of an intervention:
41,47,57
 that is, related to the assessment of a theory of 
change or a mechanism whereby an intervention is expected to operate. The GEPHI system 
recommends assessing confidence in the overall causal pathway between an intervention and 
distal outcomes (referred to as rating of coherence of evidence) with regard to the evidence 
informing each individual link in the causal pathway.
41
 It describes this domain specifically 
in the context of interventions that involve complex causal pathways, where evidence directly 
linking the intervention with the distal outcomes is frequently unavailable. Similarly, by 
using analytic frameworks the USPTSF system rates certainty of evidence in the overall 
chain of evidence for a specific preventive service.
47
 The system described by Tang and 
colleagues (2007) included assessment of the known mechanisms of action as a domain of 
evidence for rating of the quality of a body of evidence: ―if the theoretical basis is not known, 
the strength of evidence will be less convincing”.57  
3.5 Development and dissemination of the evidence rating systems  
Figure 2 describes how authors report procedures underpinning the development and 
dissemination of the systems. With regard to the preparatory activities for developing the 
system, only four systems empirically demonstrated the need for developing a new evidence 
rating system by referring to a separate publication by the same research team providing a 
critical appraisal of existing systems.
38,43,45,48
 More frequently systems reported participants 
involved in the development of the system, and only four systems described obtaining 
funding for developing the system.
36,48,50,52
 None reported conducting a Delphi process to 
develop the system, and only five reported hosting an expert meeting. However, with the 
exception of the GRADE approach, these systems did not provide further details on how 
these meetings were organised.
38,44,48,50,58
 The GRADE Working Group, on the other hand, 
organises annual meetings lasting two to three days, where members of the group have an 
opportunity to meet face-to-face and further discuss and develop and refine aspects of the 
GRADE methodology.
7
 
Regarding the write-up and dissemination activities, only three systems described 
how the publication introducing the system was developed,
44,48,50
 while instructions for using 
the systems were predominantly described in the same document that introduced it. In six 
instances, willingness to incorporate the feedback of users and update the systems was 
mentioned.
37,38,40,43,44,48
 Finally, although the majority of the systems are available online, 
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information regarding adherence to or translation of the systems—was not reported for any 
system except for GRADE (further details on this can be found on the website of the GRADE 
Working Group).
7
 The GRADE approach was also unique in involving ongoing working 
groups aiming to continually advance and expand the applicability of its methodology in step 
with developments in the area of evidence synthesis and assessment.  
4. Discussion  
4.1. “State of the field” map of evidence rating systems for health and social interventions 
This systematic review set out to describe the content, development and dissemination 
of the systems for rating the quality of a body of evidence on intervention effectiveness 
across health and social policy.  The review identified 17 systems that have made useful 
contributions to rating the quality of a body of evidence in health and social research 
synthesis. While this review identified domains of evidence that were commonly reported 
across the systems, there was significant variation in the specifications for these domains. 
Systems used different terminology to denote similar constructs of evidence when rating the 
quality of a body of evidence. Systems also varied in how they operationalised the domains 
of evidence, that is, in whether they described specific criteria and provided guidance for 
assessing each domain in an operationalisable manner. This review also identified domains of 
evidence that were found only in a few systems (see Figure 1). In general, the discrete set of 
domains identified in our review can be viewed to largely follow the ―viewpoints for 
causation‖ proposed by Sir Austin Bradford Hill,59 although the relative coverage of these 
criteria across the included systems varies. For example, domains of evidence that will 
correspond to the Hill’s criteria of experiment (study design and study execution), strength of 
association (magnitude of effect), consistency and dose-response gradient have been reported 
more extensively in evidence rating systems. Meanwhile, our review found only three 
systems, which considered domains corresponding to the Bradford Hill viewpoints of 
plausibility and coherence of evidence, and only one system included a domain on the 
analogous evidence. This can partly be explained by the challenges of developing an 
operational framework in research synthesis to assess the evidence against these criteria, 
including the need to search and integrate different sources of evidence.
60
  
As this systematic review aimed to consider evidence rating systems across health and 
social policy, the identified variation in the terminology and description of evidence domains 
may partly reflect how research synthesis and its practice differs across policy areas and types 
of interventions. One of the most contested topics in the discussions of the quality of a body 
of evidence relates to the hierarchy of evidence initially described in the paradigm of 
evidence-based medicine as an approach to differentiate between weak and strong study 
designs for assessing intervention effectiveness.
61
 While different versions of the evidence 
hierarchy have been described in clinical medicine, all of them place study designs such as 
case series (considered relatively weaker in terms of protecting against threats to internal 
validity) in the bottom of the hierarchy, followed by case-control and cohort studies in the 
middle and RCTs at the top.
62
 As our findings demonstrate, this evidence hierarchy approach 
is still used in many evidence rating systems, and particularly those developed and employed 
in clinical medicine. The widely adopted GRADE approach also follows this approach by 
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way of describing two broad categories of study designs as a starting point for the body-of-
evidence rating process (RCT evidence is initially rated as ―high‖ quality and non-RCT 
evidence as ―low‖ quality). By contrast, our findings show that systems which are used in 
broader policy areas, such as public health, tend to allow more flexibility for differentiating 
between the many types of non-RCT designs within their constructions of evidence 
hierarchies (see section 3.4.1 and Table 1). This practice is commensurate with a view that 
quasi-experimental approaches should be given appropriate provisions in evidence rating 
systems as valuable methods for making causal inferences for public health interventions.
63
  
Consistency of the body of evidence was another frequently reported domain of 
evidence in the included systems. Our findings demonstrate that evidence rating systems 
currently conceptualise consistency as similarity in the magnitude and direction of effect 
estimates across studies (of same or similar design) included in the body of evidence. There 
are however concerns that this approach only partly reflects the central tenet of scientific 
method, specifically that findings are replicable across ―a variety of situations and 
techniques‖.59 From this perspective, there are suggestions for a broader interpretation of the 
consistency of evidence to also consider ―triangulation of evidence‖ across different 
methodological approaches when arriving at overall conclusions about intervention 
effectiveness.
64
 Triangulation has been defined as integration of evidence from several 
different methodological approaches (different study designs and analytical approaches), 
which address the same underlying causal question, but which vary in terms of key sources of 
potential bias (for example, multivariable regression, instrumental variables and RCTs).
65
 
The importance of evidence triangulation has been cogently argued in the context of public 
health interventions involving longer causal pathways and multiple targets and behaviours, 
such as smoking or alcohol consumption, which are difficult (or impossible) to evaluate with 
RCTs alone. When the results from different methodological approaches are consistent in that 
they all point to the same conclusion, this is argued to strengthen the confidence in the overall 
findings (see Lawlor et al., 2016).
65
 Our review identified only one system which extended 
the domain of consistency to consider evidence from different study designs.
41
 Its broad 
interpretation, which looks at evidence from different methodological approaches to inform 
the rating of the quality of a body of evidence was unique within our findings (see section 
3.4.3). 
Our review identified very few instances where systems provided a definition for the 
construct of the quality of the body of evidence (see section 3.3). The few reported 
definitions mainly focus on the confidence in a direct estimate of the effect of an 
intervention—a definition initially suggested by GRADE. It is worth noting here, that the 
most recent publication of the GRADE Working Group clarifies this definition of the quality 
of a body of evidence based on a priori defined threshold and the context of the review.
66
The 
quality of a body of evidence is currently conceptualised to reflect the extent to which 
reviewers can be confident that ―the true effect for a specific outcome lies on one side of a 
specified threshold or within a chosen range‖.66 The revised guidance suggests three types of 
ratings: non-contextualised, partly contextualised and fully contextualised (see Table 2 for 
more details). In this new conceptualisation, the quality of a body of evidence ratings are 
explicitly acknowledged to be contingent upon a priori defined thresholds of what may be 
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considered as meaningful effects in different contexts. These thresholds and the resultant 
ratings may therefore vary depending on the context and purpose of the review.  
With regard to the activities underpinning the development and dissemination of the 
included systems, our review found that the majority of the systems did not report a 
comprehensive literature review or a consensus-based procedure for developing the system 
(see Figure 2). In a similar vein, we found little reporting of how these systems were written 
up and further disseminated. It therefore remains difficult to assess how the described 
domains of evidence have been conceptualised and the degree to which they are, or are not, 
the product of scientific consensus.  In the meantime, if not properly developed and 
disseminated, these systems may have limited value and use in research synthesis.
26
 In this 
regard, our review shows that the GRADE approach is one of the most comprehensive and 
transparent evidence rating systems in its guidance as well as its development and 
dissemination.
7
  
 
4.2. Strengths and limitations 
This review’s unique contribution may lie in its thorough exploration of the content, 
development and dissemination of the existing systems for rating the quality of a body of 
evidence across a range of policy areas, following systematic searches of bibliographic 
databases and sources of grey literature. Consequently, this review provides a comprehensive 
inventory of evidence domains considered when assessing quality of a body of evidence in 
research syntheses on intervention effectiveness across not just health, but social policy as 
well.  Considering the acknowledged challenges associated with locating evidence rating 
systems through formal literature searches,
22
 we decided to balance the searches of scientific 
databases with an extensive search of grey literature, including 83 websites and databases of 
key stakeholder organisations. Furthermore, we complemented these searches with expert 
consultations to help locate these additional sources.   
We note several limitations worth considering when interpreting our findings. First, 
we had to limit the scope of our review because of practical considerations. For instance, we 
included documents published in English only, and therefore might have missed relevant 
work from the non-English literature. Furthermore, given the identified variation in the 
terminology of the evidence domains, the mapping of these domains necessarily involved a 
degree of interpretation. It is therefore possible that another team of reviewers might have 
produced a different mapping of the domains with different conceptual categories. For 
example, another review team may have interpreted the broad evidence domain of the 
―efficacy data‖ of the Highest Attainable Standard of Evidence (HASTE) system58 as 
referring to the strength of association and therefore in the map classified under the category 
of the ―measures of precision‖, rather than consistency as we currently did. To address this 
concern, the initial mapping of evidence domains by the first author was independently 
verified by a second reviewer, and all issues were further discussed and clarified in the team. 
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4.3. Concluding remarks 
The mapping of evidence domains presented in this review aims to clarify how 
domains of evidence for rating the quality of a body of evidence on intervention effectiveness 
have been specified, developed and disseminated across health and social policy.  We see two 
broad applications of our mapping of evidence domains. First, it can serve as an aid for 
researchers to help choose the evidence rating system and corresponding domains of evidence 
most suitable for their research focus and context of work. Second, by delineating important 
gaps in the content, development and dissemination of current systems, it can indicate areas 
that may need further methodological development. It is worth noting that our mapping of 
domains should not be regarded as an expert advice on the best system for assessing the 
quality of a body of evidence on intervention effectiveness, but rather should be considered 
as a ―state of the field‖ description and interpretation of the content and the processes of 
development and dissemination based on the information reported in the included systems. 
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Figure 1. Reporting of the domains of evidence in the evidence rating systems for health and 
social interventions 
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Figure 2. Reporting of the activities for developing and disseminating the evidence rating 
systems for health and social interventions 
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Figure 3. Systematic review PRISMA flow diagram 
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Table 1. Overview of the evidence rating systems for health and social interventions 
First author (year) 
Name of the system/organisation  
Domains of evidence Notes on the domains of evidence Evidence ratings Evidence 
synthesis 
approach  
Context of 
application 
Baral (2012)  
The Highest Attainable Standard of 
Evidence (HASTE)  
“…focuses on triangulation of three distinct 
categories of evidence” (p. 572) 
1. Efficacy data  
2. Implementation dataa 
3. Plausibility dataa 
1. Consistent; inconsistent; limited 
2. Consistent; inconsistent; limiteda 
3. High; low; undefineda 
 
 
• Grade 1 (strong)  
• Grade 2 (conditional) 
• Grade 2a (probable) 
• Grade 2b (possible)     
• Grade 2c (pending) 
• Grade 3 (insufficient) 
• Grade 4 (inappropriate) 
Not specified Guideline 
development in 
public health 
(specific focus 
on HIV/AIDs 
interventions) 
Berkman (2013) 
Agency for Healthcare Research and 
Quality (AHRQ)  
“…confidence in systematic review 
conclusions so that decision-makers can use 
them effectively” (p. 1) 
1. Study Design 
2. Study limitations  
3. Directness 
 
4. Consistency 
 
5. Precision 
6. Reporting bias 
 
 
7. Dose-Response 
8. Plausible confounding 
9. Magnitude of effect 
10. Applicabilitya 
1. High (RCTs); Low (non-RCTs) 
2. Risk of bias in RCTs/non-RCTs 
3. Divergence from the outcomes & 
comparisons of interest 
4. Consistency in magnitude or 
direction  
5. Sample size, width of 95% CI 
6. Publication bias; selective outcome 
reporting bias; selective analysis 
reporting 
7. Dose-response relationship 
8. Counteracting confounding 
9. Size of the estimate of the effect 
10. Likelihood of expected results 
under the ―real-world‖ conditionsa 
• High 
• Moderate 
• Low 
• Insufficient 
 
 
 
Quantitative: meta-
analysis or 
narrative synthesis  
 
Evidence 
synthesis in 
clinical 
medicine 
Briss (2000)  
The Guide to Community Preventive 
Services 
“…confidence that changes in outcomes are 
attributable to the interventions” 
 (p. 38) 
1. Design suitability 
 
 
2. Quality of study execution 
 
3. Number of studies 
4. Consistent 
5. Effect size 
6. Applicabilitya 
7. Barriers to implementationa 
8. Economic evaluationsa 
9. Other effectsa 
1. Greatest (concurrent comparison); 
moderate (comparison, but not 
concurrent); least (single group) 
2. 6 categories of threats to validity:  
good, fair or limited 
3. – 
4. Consistent in direction & size 
5. Defined on a case-by-case basis 
6. Applicability to local situationsa 
7. –  
8. –  
9. Evidence on harmsa 
• Strong 
• Sufficient  
• Insufficient 
 
 
 
 
 
 
Quantitative: meta-
analysis or 
narrative synthesis  
 
Guideline 
development in 
public health 
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Table 1. (Continued) 
First author (year) 
Name of the system/organisation  
Domains of evidence Notes on the domains of evidence Evidence ratings Evidence 
synthesis 
approach  
Context of 
application 
Bruce (2014)  
Grading of evidence for public health 
interventions (GEPHI) 
“…it is useful to make a distinction between: 
(a) strength of evidence for causal inference, 
for which Bradford Hill viewpoints for 
distinguishing causation from association in 
environmental epidemiology are often 
referred to…, and (b) the quality of evidence 
for the intervention effect size (confidence in 
the estimate), for which GRADE may be 
used” (p. 11) 
1. Study Design 
 
 
2. Study limitations  
3. Indirectness 
4. Inconsistency 
5. Imprecision 
6. Reporting bias 
7. Dose-Response 
8. Plausible confounding 
9. Magnitude of effect 
10. Analogy 
 
11. Consistency 
 
12. Coherence 
1. High (RCTs); Moderate (quasi-
experimental designs); Low (other 
observational designs) 
2. Risk of bias in RCTs/non-RCTs  
3. Divergence from the PICO elements  
4. Heterogeneity in the effect estimates  
5. Sample size, width of 95% CI 
6. Failure to identify studies 
7. Dose-response relationship 
8. Counteracting plausibility 
9. Size of the estimate of the effect 
10. Supporting evidence with similar 
mechanisms 
11. Consistent evidence across different 
settings 
12. Coherence in the overall causal chain: 
high, moderate, weak (separate rating) 
• High 
• Moderate 
• Low 
• Insufficient 
 
 
 
 
Quantitative: meta-
analysis or 
narrative synthesis  
 
Guideline 
development in 
public health 
Clark (2009)  
Let Evidence Guide Every New Decision 
(LEGEND) 
“The term „level‟ was important to nurses to 
indicate the quality of an individual article; 
while „grade‟ was more familiar to doctors 
and was adopted to indicate the quality of a 
body of evidence” (p. 1057) 
1. Study Quality  
 
 
 
 
 
 
2. Consistency 
 
3. Number of Studies 
1. The aggregate quality ratings for 
individual studies (categorised based on 
an evidence hierarchy; e.g. 1a –  good 
quality systematic review, 1b –  lesser 
quality systematic review, 2a – good 
quality RCT/CCT; 2b – lesser quality 
RCT/CCT; etc.) 
2.  The extent to which similar findings are 
reported: Yes; No; Not available 
3. –  
• High 
• Moderate 
• Low 
• Grade-Not-Assignable 
 
 
 
Not specified 
 
 
 
 
 
 
 
Guideline 
development in 
clinical 
medicine 
 
 
 
 
 
DFID (2014)  
Assessing the Strength of Evidence 
“This Note assumes that the overall 
„strength‟ of a body of evidence is 
determined by the “avoidance of bias” of 
studies that constitute it, and by the size, 
context and consistency” (p. 3) 
1. Quality 
 
2. Size of the body of 
evidence 
3. Consistency 
4. Context of the body of 
evidence 
1. Assessed with regards to 7 domains: high; 
moderate; low 
2. Large; medium small 
 
3. Consistent; inconsistent; mixed 
4.  Global; context-specific 
 
 
 
• Very Strong 
• Strong 
• Medium  
• Limited 
• No evidence 
Not specified 
 
 
 
 
 
 
 
Evidence 
synthesis  in 
international 
development 
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Table 1. (Continued) 
First author (year) 
Name of the system/organisation  
Domains of evidence Notes on the domains of evidence Evidence ratings Evidence 
synthesis 
approach  
Context of 
application 
Ebell (2004)  
Strength of Recommendation Taxonomy 
(SORT) 
“We use the term level of evidence to refer 
to individual studies. The strength (or grade) 
of a recommendation for clinical practice is 
based on a body of evidence” (p. 60) 
1. Study Quality  
 
 
2.  Consistency 
1. Study Quality (combined with study 
design considerations based on an 
evidence hierarchy) 
2. Consistent; inconsistent 
 
• Level 1 (good quality) 
• Level 2 (limited 
quality) 
• Level 3 (other 
evidence) 
 
Quantitative: meta-
analysis 
Guideline 
development in 
clinical 
medicine 
Gough (2007)  
Weight of evidence: a framework for the 
appraisal of the quality and relevance of 
evidence 
“Weight of evidence is a useful heuristic for 
considering how to make separate 
judgements on different generic and review 
specific criteria ” (p. 11) 
1. Relevance of research 
design 
 
2. Study execution  
 
 
3. Relevance of the 
focus/context of evidence 
1. A review specific judgement about the 
appropriateness of that form of evidence 
for answering the review question 
2. Generally accepted criteria for 
evaluating the quality of evidence 
3. A review specific judgement about the 
relevance of the focus of the evidence for 
the review question 
• Weight of Evidence A 
• Weight of Evidence B  
• Weight of Evidence C  
• Weight of Evidence D  
Not specified 
(different 
quantitative and 
qualitative 
approaches) 
Evidence 
synthesis in 
education 
Guyatt (2011) 
GRADE: grading of recommendations 
assessment, development and evaluation 
“confidence that the estimates of the effect 
are correct” (p. 385) 
1. Study Design 
2. Study limitations  
3. Indirectness 
4. Inconsistency 
5. Imprecision 
6. Publication bias 
7. Dose-Response 
8. Plausible confounding 
9. Magnitude of effect 
1. High (RCTs); Low (non-RCTs) 
2. Risk of bias in RCTs/non-RCTs  
3. Divergence from the PICO elements  
4. Heterogeneity in effect estimates 
5. Sample size, width of 95% CI 
6. Failure to identify studies 
7. Dose-response relationship  
8. Counteracting confounding  
9. Size of the estimate of the effect  
• High 
• Moderate  
• Low  
• Very low 
 
 
 
 
Quantitative: meta-
analysis or 
narrative synthesis  
 
Evidence 
synthesis & 
guideline 
development in 
clinical 
medicine & 
public health 
Hillier (2011)  
FORM: An Australian method for 
formulating and grading recommendations 
in evidence-based guidelines 
“…considering all of these elements across 
all of the research studies addressing the 
clinical question as a whole (the „body of 
evidence‟)” (p. 2) 
1. Evidence Base  
 
 
 
 
 
 
2. Consistency 
3. Clinical Impact 
4. Applicability 
5. Generalisability  
1. Quality; quantity and study design 
(evidence hierarchy: Level I – systematic 
reviews of RCTs; Level II – RCTs, Level 
III-1 – pseudorandomised trial; Level III-
2 – comparative study with concurrent 
control; Level III-3 – comparative study 
without concurrent controls) 
2. Excellent; good; poor 
3. Very large; substantial; moderate; slight  
  4.   Excellent; good; satisfactory; poor 
  5.   Excellent; good; satisfactory; poor 
• A (evidence trusted) 
• B (evidence mostly 
trusted) 
• C (some support) 
• D (weak evidence) 
Not specified Guideline 
development in 
clinical 
medicine and 
public health 
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Table 1. (Continued) 
Joanna Briggs Institute (2014)  
Levels of evidence and grades of 
recommendations 
“One of the main reason for continuing with 
Levels of Evidence system is  to assist in 
assigning GRADE pre-rankings…” (p. 4) 
1. Study Design 
 
 
2. The remaining domains 
of evidence follow those 
of the GRADE approach 
1. Level 1: experimental; Level 2: quasi-
experimental; Level 3: Observational-
Analytic; Level 4: Observational-
Descriptive; Level 5: Expert opinion 
• High 
• Moderate 
• Low 
• Insufficient 
 
Quantitative: meta-
analysis or 
narrative synthesis  
 
 
 
Evidence 
synthesis in 
clinical 
medicine & 
public health 
Johnson (2015)  
Introducing EMMIE: an evidence rating 
scale to encourage mixed-method crime 
prevention synthesis 
“…in addition to considering the extent to 
which evaluations manage to rule out biases 
that might distort estimates of effect size, we 
also need to gauge the extent to which they 
contribute to understanding of the 
contexts/moderators” (p. 462) 
1. Effects 
 
2. Mechanisms/Mediatorsa 
 
3. Moderators/Contextsa 
 
4. Implementationb 
 
5. Economic analysisa 
1. Consideration of evidence validity 
elements 
2. Reference to and/or test of theory of 
changea 
3. Reference to and/or analysis of data 
relating to pre-defined moderatorsa 
4. Account of implementation or 
implementation challengesa 
5. Estimation of marginal, total or 
opportunity costsa 
Promotes descriptive 
profiles rather than a 
single overall score 
Mixed-method 
synthesis 
Evidence 
synthesis in 
criminology 
National Institute for Health and Care 
Excellence (NICE, 2012)  
Methods for the development of NICE 
Public Health Guidance 
“strength of evidence – reflecting the 
appropriateness of the study design to 
answer the question and the quality, quantity 
and consistency of evidence” (p. 89) 
1. Study design 
2. Quality 
 
3. Quantity 
4. Consistency 
5. Direction of the effecta 
6. Size of the effecta 
7. Applicabilitya 
1. Appropriateness to answer the question 
2. Assessment of both internal and external 
validity 
3. –  
4. –  
5. Positive; Negative; Mixed; Nonea 
6. Small; Medium; Largea 
7. Applicability of evidence in terms of 
PICO elementsa 
• No evidence 
• Weak evidence 
• Moderate evidence 
• Strong Evidence 
• Inconsistent Evidence 
Quantitative: meta-
analysis or 
narrative synthesis  
 
Qualitative for 
questions other 
than intervention 
effectiveness 
Guideline 
development in 
public health 
Sawaya (2007)  
U.S. Preventive Services Task Force 
(USPSTF) 
“The U.S. Preventive Services Task Force 
(USPSTF) defines certainty as “likelihood 
that the USPSTF assessment of the net 
benefit of a preventive service is correct” 
 (p. 873) 
1. Study Design 
 
 
 
 
2. Study Quality  
3. Generalisability 
4. Quantity  
5. Consistency 
6. Other 
1. Evidence hierarchy (Level I – RCT; Level 
II-1 – controlled trial without 
randomisation; Level II-2 – cohort and 
case-control; Level II-2 – multiple time 
series; Level III - opinions) 
2. Design specific: good; fair; poor 
3. –  
4. –  
5. –  
6. Dose-response; fit within a biologic model  
Chain of evidence: 
• High  
• Moderate 
• Low 
Not specified 
 
 
 
 
 
 
 
 
 
 
 
Guideline 
development in 
clinical 
medicine 
Table 1. (Continued) 
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First author (year) 
Name of the system/organisation  
Domains of evidence Notes on the domains of evidence Evidence ratings Evidence 
synthesis 
approach  
Context of 
application 
Tang (2007)  
Grading of evidence of the effectiveness of 
health promotion interventions 
“…the strength of evidence can be graded 
by using three criteria” (p. 832) 
1. Association 
 
 
2. Repeatability  
 
3. How it works 
1. High (risk ratio of 2 or more) and 
statistically significant association: high, 
low, none 
2. Reflects the consistency of the findings in 
different settings: wide, limited, none 
3. Reflects the known cause-effect 
mechanism for the intervention under 
study: known; not known 
• Grade 1 (strong)  
• Grade 2A (probable)  
• Grade 2B (possible)  
• Grade 2C (limited) 
• Grade 3 (insufficient) 
 
 
Not specified Evidence 
synthesis in 
public health 
Treadwell (2006)  
A system for rating the stability and 
strength of medical evidence 
“Our system draws a distinction between 
two types of conclusions: quantitative and 
qualitative…a quantitative conclusion 
characterises the size of the effect, whereas a 
qualitative conclusion characterises the 
direction of the effect” (p. 6) 
1. Quality 
2. Quantity 
 
 
3. Informativeness 
4. Homogeneity 
5. Robustness 
 
1. High; moderate; low; very low 
2. Criterion met; criterion not met (at least 3 
studies and 80% having calculable effect 
sizes) 
3. Effect Size 
4. Homogeneous; heterogeneous 
5. Tested through sensitivity analysis: 
robust; not robust 
• Strong 
• Moderate  
• Weak 
• Inconclusive 
Quantitative: meta-
analysis 
Evidence 
synthesis in 
clinical 
medicine 
Turner-Stokes (2006)  
Generating the evidence base for the 
National Service Framework for long term 
conditions: a new research typology 
“Each individual recommendation is then 
given an overall „grade of research 
evidence‟ rating of A, B or C based on the 
quality of all the evidence supporting it and 
how much of it was directly relevant” (p. 97) 
1. Type of evidence 
 
 
 
2. Study quality 
 
3. Applicability 
1. Primary research-based; secondary 
research-based; review-based (no 
classification based on an evidence 
hierarchy) 
2. Quality is assessed on the basis of 5 
questions to reach a max. score of 10 
(includes a question on the 
appropriateness of the study design) 
3. Population context of the study: direct; 
indirect 
• GRADE A  
• GRADE B 
• GRADE C 
 
Quantitative: meta-
analysis or 
narrative synthesis  
 
Qualitative for 
questions other 
than intervention 
effectiveness 
Evidence 
synthesis in 
clinical 
medicine & 
public health 
aThese domains of evidence go beyond rating the quality of a body of evidence on intervention effectiveness and are used in systems to further inform grading of the recommendations for 
practice. In the GRADE approach, these domains are separately specified as ―Evidence to Decision‖ criteria (see Alonso-Coello et al., 2016). 
Notes: CCT – controlled clinical trial; CI – confidence interval; DFID – Department for International Development; PICO – population, intervention, comparison, outcomes; RCT – randomised 
controlled trial;  
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Table 2. Approaches to defining certainty of evidence in GRADE (adapted from Hultcrantz et al., 2017)66 
Setting Degree of 
contextualisation 
Threshold or range How to set What certainty 
rating represents 
Primarily for 
systematic reviews 
and health 
technology 
assessment 
Non-contextualised 
Range: 95% CI Using existing limits 
of the 95% CI 
Certainty that the 
effect lies within the 
confidence interval 
OR≠1; RR≠1; HR≠1; 
RD≠0 
Using the threshold 
of null effect 
Certainty that the 
effect of one 
treatment differs 
from another 
Primarily for 
systematic reviews 
and health 
technology 
assessment 
Partially-contextualised Specified magnitude 
of effect 
E.g., small effect is 
the effect small 
enough to not use the 
intervention if 
adverse effects/costs 
are appreciable 
Certainty in a 
specified magnitude 
of effect for one 
outcome (e.g., trivial, 
small,  moderate or 
large) 
Primarily for 
practice guidelines 
Fully-contextualised 
Threshold determined 
with consideration of 
all critical outcomes 
Considering the 
range of effects on all 
critical outcomes, 
and the values & 
preferences 
Confidence that the 
direction of the net 
effect will not differ 
from one end of the 
certainty range to the 
other 
Notes: CI = ―Confidence Interval‖. GRADE = ―Grading of Recommendations Assessment, Development and Evaluation‖. 
HR = ―Hazard Ratio‖. OR = ―Odds Ratio‖. RD = ―Risk Difference‖. RR = ―Risk Ratio‖. 
